This includes program and protocol development, regulatory consultancy, study management, medical monitoring and pharmacovigilance, central laboratory services, data management, statistical evaluation and medical writing.
In recent years, ICON has been involved in clinical studies and programs in the following CNS indications/areas:
ICON has a major group of project managers and CRAs with CNS experience. In order to ensure up-to-date knowledge and high quality, these teams are trained, supported and advised by ICON’s CNS Therapeutic Area Group (TAG). The CNS TAG is comprised of international specialists qualified in psychiatry, neurology, psychopharmacology, or psychology and/or with extensive operational experience in CNS studies. The TAG is responsible for therapeutic oversight, gives input into feasibility projects, strategic planning of country and site distribution of projects, and provides Medical Monitor services. The TAG is available for consulting service, identification of Key Opinion Leaders, and the set up of advisory boards.